Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.

Characteristics of patients with serum antibodies to extractable nuclear antigens.

Procainamide, acetylprocainamide, and drug-induced lupus erythematosus.

Kinetics of procainamide and N-acetylprocainamide in renal failure.

Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.

Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.

Effects of N-acetylprocainamide as compared with procainamide in isolated rat atria.

Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.

Precaution in use of high-pressure liquid chromatographic simultaneous plasma procainamide and N-acetylprocainamide determination.

Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.

Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.

Simultaneous determination of procainamide and N-acetylprocainamide in plasma by high-performance liquid chromatography.

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics.

Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide.

Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE.

N-Acetylprocainamide levels in patients with end-stage renal failure.

Antibodies to cellular antigens in Sjögren's syndrome.

Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).

The incidence and clinical significance of antibodies to extractable nuclear antigens.

Serum IgG subclass antibodies to a variety of food antigens in patients with coeliac disease.

Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders.

Development of antibodies to ribonucleoprotein following short-term therapy with procainamide.

Peripheral neuropathies associated with antibodies directed to intracellular neural antigens.

Monoclonal antibodies to renal cancer antigens.

Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.

Suggest Documents

Characteristics of patients with serum antibodies to extractable nuclear antigens.

Procainamide, acetylprocainamide, and drug-induced lupus erythematosus.

Kinetics of procainamide and N-acetylprocainamide in renal failure.

Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.

Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.

Effects of N-acetylprocainamide as compared with procainamide in isolated rat atria.

Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.

Precaution in use of high-pressure liquid chromatographic simultaneous plasma procainamide and N-acetylprocainamide determination.

Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.

Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.

Simultaneous determination of procainamide and N-acetylprocainamide in plasma by high-performance liquid chromatography.

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics.

Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide.

Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE.

N-Acetylprocainamide levels in patients with end-stage renal failure.

Antibodies to cellular antigens in Sjögren's syndrome.

Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).

The incidence and clinical significance of antibodies to extractable nuclear antigens.

Serum IgG subclass antibodies to a variety of food antigens in patients with coeliac disease.

Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders.

Development of antibodies to ribonucleoprotein following short-term therapy with procainamide.

Peripheral neuropathies associated with antibodies directed to intracellular neural antigens.

Monoclonal antibodies to renal cancer antigens.

Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.

Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.

Recommend Documents

Follow Us